Find Clinical Trials & Studies

Visit the Research & Education Institute

A Phase 1 Dose-Escalation Study of SLV-324 in Subjects with Metastatic Solid Tumors

I'm Interested!

Please call
1-866-373-1464

A Phase 1 Dose-Escalation Study of SLV-324 in Subjects With Metastatic Solid Tumors

Sex: Any
Age: Adult (18 - 64), Older Adult (65+)
Accepting Healthy People: No
Type: Interventional / Therapeutic
Trial Phase: Phase I
Conditions Being Studied: Cancer - Solid Tumor

Study Purpose

This is a Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, pharmacodynamics, immunogenicity, and efficacy of SLV-324 across a range of dose levels when administered to subjects with metastatic solid tumors.

Principal Investigator
Afshin Dowlati MD

Department/Division
Cancer (Any Solid Tumor)

UH IRB: STUDY20250726
StudyID: SOLV1Y25
ClinicalTrials.gov: NCT07108114

I'm Interested!

Please call
1-866-373-1464

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-866-373-1464